News Detail

Mumbai, 4 March 2025: AstraZeneca Pharma India Ltd on Monday said it has received approval from drug regulator CDSCO to import and distribute cancer treatment medicine Durvalumab solutions in the country.
The approval by the Central Drugs Standard Control Organisation ......
View Details
Source : AstraZeneca Pharma India Ltd
Cancer treatment medicine in India
AstraZeneca
cancer drugs
Medicine
Central Drugs Standard Control Organisation (CDSCO)
Related News
- Karnataka notifies NDPS Rules, Essential Narcotic Drugs to be regulated under Central Rules (22-03-2025)
- One hundred teams participated in 'Operation Garuda', uncovering nearly 40 different types of drugs being sold without prescriptions (22-03-2025)
- List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)
- DCA seized four medicines for misleading 'Leucoderma', 'Tuberculosis' and 'Fever' treatment claims (21-03-2025)
- Skin specialists flag widespread quackery in Kerala (21-03-2025)
- SHRC orders criminal proceedings against fake doctor (21-03-2025)
- Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)
- CEPI and AstraZeneca to advance discovery into novel antibody (21-03-2025)
- FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)
- Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India (20-03-2025)